CETP and Alzheimer disease: Given our sample size (34,174 individuals, 47% cases) and the proportion of variance explained in HDL by the CETP SNPs (3.5%), we had >80% power to detect an odds ratio > 1.18 or < 0.85 for genetically increased HDL on risk of AD at an alpha of 0.05.